These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 20430946)

  • 1. p-Cresol and cardiovascular risk in mild-to-moderate kidney disease.
    Meijers BK; Claes K; Bammens B; de Loor H; Viaene L; Verbeke K; Kuypers D; Vanrenterghem Y; Evenepoel P
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1182-9. PubMed ID: 20430946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD.
    Carrero JJ; Kyriazis J; Sonmez A; Tzanakis I; Qureshi AR; Stenvinkel P; Saglam M; Stylianou K; Yaman H; Taslipinar A; Vural A; Gok M; Yenicesu M; Daphnis E; Yilmaz MI
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):207-15. PubMed ID: 22193237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.
    Poesen R; Evenepoel P; de Loor H; Kuypers D; Augustijns P; Meijers B
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1136-1144. PubMed ID: 27084876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease.
    Poesen R; Viaene L; Verbeke K; Augustijns P; Bammens B; Claes K; Kuypers D; Evenepoel P; Meijers B
    BMC Nephrol; 2014 Jun; 15():87. PubMed ID: 24912660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between IL-10 levels and cardiovascular events in patients with CKD.
    Yilmaz MI; Solak Y; Saglam M; Cayci T; Acikel C; Unal HU; Eyileten T; Oguz Y; Sari S; Carrero JJ; Stenvinkel P; Covic A; Kanbay M
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1207-16. PubMed ID: 24789549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4.
    Goicoechea M; de Vinuesa SG; Gómez-Campderá F; Aragoncillo I; Verdalles U; Mosse A; Luño J
    Kidney Int Suppl; 2008 Dec; (111):S67-70. PubMed ID: 19034331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease.
    Yilmaz MI; Sonmez A; Qureshi AR; Saglam M; Stenvinkel P; Yaman H; Eyileten T; Caglar K; Oguz Y; Taslipinar A; Vural A; Gok M; Unal HU; Yenicesu M; Carrero JJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1617-25. PubMed ID: 21700826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free p-cresol is associated with cardiovascular disease in hemodialysis patients.
    Meijers BK; Bammens B; De Moor B; Verbeke K; Vanrenterghem Y; Evenepoel P
    Kidney Int; 2008 May; 73(10):1174-80. PubMed ID: 18305466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.
    Rebholz CM; Grams ME; Matsushita K; Inker LA; Foster MC; Levey AS; Selvin E; Coresh J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):941-8. PubMed ID: 25825481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiogram abnormalities and cardiovascular mortality in elderly patients with CKD.
    Dobre M; Brateanu A; Rashidi A; Rahman M
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):949-56. PubMed ID: 22461533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The uremic retention solute p-cresyl sulfate and markers of endothelial damage.
    Meijers BK; Van Kerckhoven S; Verbeke K; Dehaen W; Vanrenterghem Y; Hoylaerts MF; Evenepoel P
    Am J Kidney Dis; 2009 Nov; 54(5):891-901. PubMed ID: 19615803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease.
    Lu TM; Chung MY; Lin CC; Hsu CP; Lin SJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1566-72. PubMed ID: 21642363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prognosis of acute kidney injury after first acute stroke.
    Tsagalis G; Akrivos T; Alevizaki M; Manios E; Theodorakis M; Laggouranis A; Vemmos KN
    Clin J Am Soc Nephrol; 2009 Mar; 4(3):616-22. PubMed ID: 19211666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p-Cresol sulfate: further understanding of its cardiovascular disease potential in CKD.
    Winchester JF; Hostetter TH; Meyer TW
    Am J Kidney Dis; 2009 Nov; 54(5):792-4. PubMed ID: 19853197
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.
    Shafi T; Sirich TL; Meyer TW; Hostetter TH; Plummer NS; Hwang S; Melamed ML; Banerjee T; Coresh J; Powe NR
    Kidney Int; 2017 Dec; 92(6):1484-1492. PubMed ID: 28739139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.
    Goicoechea M; de Vinuesa SG; Verdalles U; Ruiz-Caro C; Ampuero J; Rincón A; Arroyo D; Luño J
    Clin J Am Soc Nephrol; 2010 Aug; 5(8):1388-93. PubMed ID: 20538833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.
    Bammens B; Evenepoel P; Keuleers H; Verbeke K; Vanrenterghem Y
    Kidney Int; 2006 Mar; 69(6):1081-7. PubMed ID: 16421516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era.
    Appleby CE; Ivanov J; Lavi S; Mackie K; Horlick EM; Ing D; Overgaard CB; Seidelin PH; von Harsdorf R; Dzavík V
    Circ Cardiovasc Interv; 2009 Aug; 2(4):309-16. PubMed ID: 20031733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
    Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients.
    Chen YH; Hung SC; Tarng DC
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):567-74. PubMed ID: 21411679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.